Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Net Income | -280.69% | 74.61% | -35.31% | 11.99% | -138.56% |
Total Depreciation and Amortization | -100.00% | 56.44% | 3.59% | -0.51% | -0.51% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -200.00% | 193.22% | -186.76% | 0.00% | -11.69% |
Change in Net Operating Assets | 2,503.85% | -105.53% | 107.73% | -41.85% | 560.17% |
Cash from Operations | 213.79% | 150.00% | 54.69% | -250.59% | 1,044.44% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -157.78% | -87.97% | 1,868.42% | -- | -- |
Total Debt Repaid | -- | -- | -314.63% | 320.43% | 16.96% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -156.25% | 166.67% | -129.27% | 337.68% | 16.87% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 19.67% | 158.10% | -400.00% | 118.75% | 117.39% |